| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2005 | US6919458 Preparation of terfenadine carboxylic acid metabolite and carebastine using a 1-(2-substituted isopropyl)-4-(cyclopropylcarbonyl)-benzene compound intermediate |
| 07/19/2005 | US6919455 4-((9-((3-Cyclopentyloxy-4-methoxy)benzyl)-6,8 dimethylpurin)-2-yl-3-oxypropyl)pyridine N-oxide chemical intermediate; phosphodiesterase inhibitors; antiasthmatic and antiinflammatory agents; chronic obstructive pulmonary disease |
| 07/19/2005 | US6919450 Process for the preparation of benazepril |
| 07/19/2005 | US6919449 Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919380 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics |
| 07/19/2005 | US6919379 Compounds useful in reflux disease |
| 07/19/2005 | US6919378 Pharmaceutical solutions of modafinil compounds |
| 07/19/2005 | US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists |
| 07/19/2005 | US6919376 Therapeutic agents and corresponding treatments |
| 07/19/2005 | US6919374 Viscosity modulating substance and use thereof |
| 07/19/2005 | US6919373 Methods and devices for providing prolonged drug therapy |
| 07/19/2005 | US6919372 An ionic prostanoic acid derivative, for which sustained release is required through parenteral route, and an cationic compound form a sparingly water-soluble ionic complex; increased occtanol/water partition coefficient; hydrophobic |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/19/2005 | US6919370 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 07/19/2005 | US6919369 Controlling blood coagulation |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919366 Benzimidazole derivatives as modulators of IgE |
| 07/19/2005 | US6919363 Central nervous system disorders; antiischemic agents; analgesics |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919360 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919357 Human sexual disorders; therapy for impotency |
| 07/19/2005 | US6919356 Antihistamines, antiallergens, autoimmune disease, antiinflammatory agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919352 Viricide against herpes virus |
| 07/19/2005 | US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors |
| 07/19/2005 | US6919350 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 07/19/2005 | US6919348 1-R1- phenyl, 4-R2-phenyl substituted 1,2,3,6-tetrahydropyrimidine-2- one cold receptor agonist in a therapeutically effective amount and preferably further comprises one or more pharmaceutically active drugs such as |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919346 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 07/19/2005 | US6919345 Sulfonate substituted pyrazol pyridine derivatives |
| 07/19/2005 | US6919344 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919342 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919339 ABCA-1 elevating compounds |
| 07/19/2005 | US6919338 Antiproliferative agents; anticancer agents |
| 07/19/2005 | US6919335 Heterocycles that are inhibitors of IMPDH enzyme |
| 07/19/2005 | US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents |
| 07/19/2005 | US6919330 Formulations of drugs |
| 07/19/2005 | US6919329 Microorganisms; bactericides; human and veterinary medicine |
| 07/19/2005 | US6919328 Derivatives of dibenz(b,e)-1,4-diazepine, dibenz(b,f)-1,4-oxazepine or dibenz(b,e)-1,4-thiazepine as enzyme inhibitors of the nitric oxide synthase (NOS) isoforms synthesized in neuronal cells and macrophages; stroke |
| 07/19/2005 | US6919327 Texaphyrin coordination compounds and uses thereof |
| 07/19/2005 | US6919326 Carbonyl-stress improving agent and peritoneal dialysate |
| 07/19/2005 | US6919325 Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| 07/19/2005 | US6919324 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/19/2005 | US6919322 Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors |
| 07/19/2005 | US6919321 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 07/19/2005 | US6919317 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role |
| 07/19/2005 | US6919316 Administering to a subject in need, an immunosuppressively effective amount of at least one sulfofucosylacylglycerol compound |
| 07/19/2005 | US6919310 Administering drug formulation comprising opioidergic agent and an insulin secretagogue for therapy of human suffering from one or more conditions included within Coronary Heart Disease Risk Factor Syndrome |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919306 Method of skin care |
| 07/19/2005 | US6919208 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 07/19/2005 | US6919100 Method for coating medical devices |
| 07/19/2005 | US6919093 Formulation |
| 07/19/2005 | US6919092 Method for the management of incontinence |
| 07/19/2005 | US6919090 Active substance combinations with insecticidal and acaricidal properties |
| 07/19/2005 | US6919088 Water-soluble stable salts of petroselinic acid |
| 07/19/2005 | US6919087 And an excipient wherein the pH is within the range of 5.5-7.0; stability; dosage forms |
| 07/19/2005 | US6919072 Comprises matrix metalloproteinase (MMP) inhibitor; for promoting collagen production |
| 07/19/2005 | US6919069 Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
| 07/19/2005 | US6918927 Coated implantable medical device |
| 07/19/2005 | CA2348017C Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse |
| 07/19/2005 | CA2071248C Composition containing dioxabicyclo-[3.3.0]octane derivative |
| 07/16/2005 | WO2005077353A1 Dichloroacetate in combination with an inotrope for cardioprotection |
| 07/16/2005 | CA2489853A1 Methods of cardioprotection using dichloroacetate in combination with an inotrope |
| 07/14/2005 | WO2005064332A1 Highly active lysophosphatidic acid and method of screening therewith |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063984A1 Double-stranded dna inhibiting gene expression |
| 07/14/2005 | WO2005063807A2 Treatment of coronary or peripheral ischemia |
| 07/14/2005 | WO2005063806A1 Arginine hydrochloride enhances chaperone-like activity of alpha crystallin |
| 07/14/2005 | WO2005063790A1 Isolation of tigogenin pentaglycoside from chlorophytum nimonii |
| 07/14/2005 | WO2005063789A1 Isolation of bivittoside d from sea cucumber and activity thereof |
| 07/14/2005 | WO2005063788A1 Benzimidazole derivatives and medical uses thereof |
| 07/14/2005 | WO2005063777A1 Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation |
| 07/14/2005 | WO2005063771A1 Methods of preparing olanzapine |
| 07/14/2005 | WO2005063767A2 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 07/14/2005 | WO2005063764A2 Fused pyrrolocarbazoles and methods for the preparation thereof |
| 07/14/2005 | WO2005063762A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | WO2005063761A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | WO2005063759A1 PROCESS FOR PREPARING PYRROLO[2, 1-c] [1, 4] BENZODIAZEPINE HYBRIDS |
| 07/14/2005 | WO2005063758A1 C2-FLUORO PYRROLO[2,1-c][1,4]BENZODIAZEPINE DIMERS |
| 07/14/2005 | WO2005063757A2 Novel crystalline forms of temozolomide |
| 07/14/2005 | WO2005063756A1 Crf receptor antagonists and methods relating thereto |
| 07/14/2005 | WO2005063755A1 Crf receptor antagonists and methods relating thereto |
| 07/14/2005 | WO2005063751A1 4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity |
| 07/14/2005 | WO2005063750A1 Bicyclic imidazole compounds, the production thereof and their use as medicaments |
| 07/14/2005 | WO2005063749A1 Crf receptor antagonists and methods relating thereto |
| 07/14/2005 | WO2005063748A1 β-CARBOLINE DERIVED GUANIDINE ALKALOID, TIRUCHENDURAMINE |
| 07/14/2005 | WO2005063745A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 07/14/2005 | WO2005063744A2 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| 07/14/2005 | WO2005063743A1 Thiazole derivative |
| 07/14/2005 | WO2005063740A1 Chrysogenazine obtained from fungus penicillium chrysogenum having antibacterial activity |
| 07/14/2005 | WO2005063739A1 Novel quinoline derivatives |
| 07/14/2005 | WO2005063738A1 Novel 2-heteroaryl-substituted benzimidazole derivative |